Molecular mechanisms of insulin resistance and associated diseases

被引:188
作者
Mlinar, Barbara
Marc, Janja
Janez, Andrej
Pfeifer, Marija
机构
[1] Univ Ljubljana, Dept Clin Biochem, Fac Pharm, SI-1000 Ljubljana, Slovenia
[2] Univ Ljubljana, Ctr Med, Dept Endocrinol & Metab Dis, Ljubljana, Slovenia
关键词
diabetes mellitus type 2; insulin resistance; lipodystrophy; metabolic syndrome; obesity; polycystic ovary syndrome;
D O I
10.1016/j.cca.2006.07.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
insulin resistance is a state in which higher than normal concentrations of insulin are required for normal response. The most common underlying cause is central obesity, although primary insulin resistance in normal-weight individuals is also possible. Excess abdominal adipose tissue has been shown to release increased amounts of free fatty acids which directly affect insulin signalling, diminish glucose uptake in muscle, drive exaggerated triglyceride synthesis and induce gluconeogenesis in the liver. Other factors presumed to play the role in insulin resistance are tumour necrosis factor alpha, adiponectin, leptin, IL-6 and some other adipokines. Hyperinsulinaemia which accompanies insulin resistance may be implicated in the development of many pathological states, such as hypertension and hyperandrogenaemia. Insulin resistance underlies metabolic syndrome and is farther associated with polycystic ovary syndrome and lipodystrophies. When IS-cells fail to secrete the excess insulin needed, diabetes mellitus type 2 emerges, which is, besides coronary heart disease, the main complication of insulin resistance and associated diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 35
页数:16
相关论文
共 141 条
[101]   Insulin resistance in adipose tissue:: direct and indirect effects of tumor necrosis factor-α [J].
Ruan, H ;
Lodish, HF .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (05) :447-455
[102]   Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-α -: Implications for insulin resistance [J].
Ruan, H ;
Miles, PDG ;
Ladd, CM ;
Ross, K ;
Golub, TR ;
Olefsky, JM ;
Lodish, HF .
DIABETES, 2002, 51 (11) :3176-3188
[103]   Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes -: Nuclear factor-κB activation by TNF-α is obligatory [J].
Ruan, H ;
Hacohen, N ;
Golub, TR ;
Van Parijs, L ;
Lodish, HF .
DIABETES, 2002, 51 (05) :1319-1336
[104]   REGULATION OF INSULIN-RECEPTOR SUBSTRATE-1 IN LIVER AND MUSCLE OF ANIMAL-MODELS OF INSULIN RESISTANCE [J].
SAAD, MJA ;
ARAKI, E ;
MIRALPEIX, M ;
ROTHENBERG, PL ;
WHITE, MF ;
KAHN, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1839-1849
[105]   Insulin signalling and the regulation of glucose and lipid metabolism [J].
Saltiel, AR ;
Kahn, CR .
NATURE, 2001, 414 (6865) :799-806
[106]   Monocyte chemoattractant protein 1 in obesity and insulin resistance [J].
Sartipy, P ;
Loskutoff, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7265-7270
[107]   Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect [J].
Satoh, N ;
Ogawa, Y ;
Usui, T ;
Tagami, T ;
Kono, S ;
Uesugi, H ;
Sugiyama, H ;
Sugawara, A ;
Yamada, K ;
Shimatsu, A ;
Kuzuya, H ;
Nakao, K .
DIABETES CARE, 2003, 26 (09) :2493-2499
[108]  
SAXENA U, 1989, J BIOL CHEM, V264, P4349
[109]   Molecular mechanisms of insulin resistance [J].
Schinner, S ;
Scherbaum, WA ;
Bornstein, SR ;
Barthel, A .
DIABETIC MEDICINE, 2005, 22 (06) :674-682
[110]   Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance [J].
Schlaepfer, IR ;
Pulawa, LK ;
Ferreira, LDMCB ;
James, DE ;
Capell, WH ;
Eckel, RH .
JOURNAL OF LIPID RESEARCH, 2003, 44 (06) :1174-1181